Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Thursday, 03'rd Jul 2025
Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
GSK counts on Blenrep rebound to drive £40bn sales goal
09:45am, Thursday, 03'rd Jul 2025
GSK PLC's (LSE:GSK, NYSE:GSK) long-term growth ambitions hinge in part on Blenrep, its treatment for multiple myeloma, a type of blood cancer. With the company aiming for more than £40 billion in ann
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 02'nd Jul 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
US Senator investigates GSK for pulling children's asthma inhaler
09:11am, Friday, 27'th Jun 2025
Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for chil
Bharat, GSK to halve price of malaria vaccine by 2028
03:29am, Wednesday, 25'th Jun 2025
Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving its current cost, they said on Wednesday.
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
01:16pm, Tuesday, 24'th Jun 2025
GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
09:00am, Tuesday, 24'th Jun 2025
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector of Benlysta (belimumab), a B-lymphocyte stim
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
10:46am, Monday, 23'rd Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
11:25am, Wednesday, 18'th Jun 2025
GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine headwinds.
AstraZeneca and GSK fall after Trump renews pharma tariff threat
09:48am, Wednesday, 18'th Jun 2025
Shares in AstraZeneca PLC (LSE:AZN), the largest company on the FTSE 100 index, and fellow blue chip GSK PLC (LSE:GSK, NYSE:GSK) were down 1.4% and 1.9% respectively on renewed worries about US dru
Here's Why GSK (GSK) is a Strong Momentum Stock
10:50am, Tuesday, 17'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy
12:20pm, Monday, 16'th Jun 2025
GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for review by the EMA.
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
09:33am, Monday, 16'th Jun 2025
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic
GSK seeks broader European approval for RSV vaccine
05:01am, Friday, 13'th Jun 2025
GSK PLC (LSE:GSK, NYSE:GSK) has taken a step towards widening access to its respiratory syncytial virus (RSV) vaccine in Europe, with the European Medicines Agency accepting its application to expand
GSK says EU heath regulator reviewing expansion of RSV vaccine
02:14am, Friday, 13'th Jun 2025
GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to include adults from 18 years of age.
